Besides HIF-1α, several regulatory pathways are also known to be involved in the regulation of glucose metabolism in tumor cells, such as Myc, PI3K/Akt/mTOR and AMP-activated protein kinase (AMPK) [17, 50]. The gene discussed is AKT1; the disease is neoplasm.